All Web Images Videos News
Settings
Appearance
Site Icons
Font Size
Font
General
Infinite Scroll
Open Links in a New Tab
Safe Search
Related Questions
What role does PhRMA play in healthcare policy? A5: PhRMA actively engages in healthcare policy discussions to advocate for policies that support medical innovation, patient access, and affordability. Through research, analysis, and education, PhRMA contributes to shaping policy decisions related to drug pricing, intellectual property, regulatory pathways, and healthcare delivery.
How does PhRMA contribute to global health efforts? A10: PhRMA member companies are committed to improving global health outcomes. They collaborate with international organizations, governments, and public health initiatives to expand access to medicines in underserved regions, combat infectious diseases, and advance research that addresses global health challenges. PhRMA actively contributes resources, expertise, and innovative solutions to support global health efforts.
How does PhRMA contribute to medical innovation? A4: PhRMA member companies invest heavily in research and development (R&D), driving medical innovation globally. They conduct extensive R&D efforts to discover and develop new medicines, including rare disease treatments and breakthrough therapies. PhRMA also promotes collaboration and knowledge-sharing among stakeholders to advance scientific discoveries.
How does PhRMA address concerns about drug pricing? A6: PhRMA acknowledges the concerns associated with rising drug prices and is committed to finding sustainable solutions. They promote transparency in pricing, support value-based payment models, work to address regulatory barriers, and advocate for policies that enhance competition and drive down costs.
How does PhRMA support responsible advertising and marketing practices? A8: PhRMA and its member companies follow a strict code of conduct concerning advertising and marketing practices. They adhere to industry guidelines, ensure accurate and balanced promotion, and comply with regulatory requirements to provide clear and truthful information to healthcare professionals and patients.
What role does PhRMA play in addressing public health emergencies? A9: PhRMA collaborates with government agencies, healthcare providers, and international organizations during public health emergencies. They mobilize resources, leverage expertise, and participate in public-private partnerships to develop treatments, vaccines, and support initiatives aimed at addressing urgent healthcare needs.
How does PhRMA ensure patient safety? A2: PhRMA and its member companies prioritize patient safety through rigorous clinical trials, adherence to regulatory standards, and ongoing post-market surveillance. They actively collaborate with regulatory agencies, healthcare providers, and patient organizations to monitor drug safety, identify potential risks, and improve drug development processes.
What is phrma.org? A1: Phrma.org is the official website of the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents leading U.S. biopharmaceutical companies. It serves as a comprehensive resource for information about innovative medical research, policies, and advocacy efforts in the pharmaceutical industry.
What initiatives does PhRMA undertake to enhance diverse clinical trial participation? A7: PhRMA is actively involved in efforts to increase diversity in clinical trials, ensuring that new medicines are tested on populations that reflect real-world demographics. They collaborate with community organizations, healthcare providers, and policymakers to address barriers to participation, raise awareness, and improve representation in clinical research.
What measures does PhRMA take to promote affordability of medications? A3: PhRMA supports various policies and initiatives to enhance patient access to affordable medicines. This includes providing discounts, patient assistance programs, and working to improve insurance coverage and formulary design. PhRMA also advocates for policies that encourage competition, such as shorter exclusivity periods and streamlined regulatory pathways.